Market Overview:
The global immunoinformatics market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, rising demand for personalized medicine, and technological advancements in immunoinformatics tools and platforms. Immunoinformatics is a field of science that deals with the application of information technology (IT) tools to understand and analyze immune system data. The use of IT tools helps researchers store, manage, analyze, and visualize large amounts of data related to immunity. This helps them identify new biomarkers and targets for drug development.
Product Definition:
Immunoinformatics is the application of informatics tools and techniques to the study of immunity. The goal of immunoinformatics is to improve our understanding of immune system function and help us develop new vaccines and therapies. Immunoinformatics is important because it allows us to better understand how the immune system works, which can lead to advances in vaccine development and treatment for diseases such as cancer.
Cancer Diagnosis & Therapy:
Cancer diagnosis & therapy, it's usage.
Immunotherapy is the treatment of cancer by using the immune system. The immune system plays a very important role in cancer treatment as it can recognize and attack cancer cells. There are various types of cancers such as lung, breast, colorectal, stomach among others that require different methods of treating.
Reverse Vaccinology:
Reverse vaccinology is the new term used for immunoinformatics. Reverse vaccinology is a branch of immunoproteomics that involves computational analysis of the immune response to determine vaccine targets and assess vaccine efficacy. It also helps in finding novel biomarkers, which can be used for vaccination planning & development as well as assessment of immunity after vaccination.
Application Insights:
The allergy prediction databases segment dominated the global immunoinformatics market in 2017. This is attributed to the rising prevalence of atopic disorders, such as asthma and allergies. For instance, according to data published by Global Burden of Disease Study in 2016, around 1% to 3% of total population suffers from allergic rhinitis every year. However, only 0.5%to 1%of these cases get diagnosed and treated due to lack of awareness among patients as well as healthcare professionals about this disease.
Reverse vaccinology is anticipated to grow at a lucrative rate during the forecast period owing to its applications in cancer prevention and immunity enhancement therapy for infectious diseases such as HIV/AIDS and hepatitis A & B virus infections among others which are prevalent worldwide.
Regional Analysis:
North America dominated the global immunoinformatics market in 2017. This can be attributed to presence of key players, such as Infor Inc.; Quest Diagnostics; and Mersana Therapeutics, Inc. Moreover, increasing prevalence of cancer is also expected to drive the regional market over the forecast period. For instance, according to data published by American Cancer Society in 2018’s edition about 1,735 new cases of lung cancer were reported among men and women in U.S.
Growth Factors:
- Increasing demand for personalized medicines and companion diagnostics
- Growing number of immunotherapy drugs in development and approval process
- Rising prevalence of cancer and other immune-mediated diseases
- Proliferation of next-generation sequencing (NGS) technology for biomarker discovery and characterization
- Development of novel bioinformatics tools to support data analysis
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunoinformatics Market Research Report
By Type
Cancer Diagnosis & Therapy, Reverse Vaccinology, Immune System Modeling
By Application
Allergy Prediction Databases, Analysis Resource Database, International Immunogenetics System, The Ontology of Immune Epitopes, Immune Epitope Database
By Companies
EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group, Compugen, Genedata AG, Insilico Biotechnology AG, Leadscope Inc, Nimbus Discovery, Strand Life Sciences, Schrodinger, Simulation Plus, Rosa & Co
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Immunoinformatics Market Report Segments:
The global Immunoinformatics market is segmented on the basis of:
Types
Cancer Diagnosis & Therapy, Reverse Vaccinology, Immune System Modeling
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Allergy Prediction Databases, Analysis Resource Database, International Immunogenetics System, The Ontology of Immune Epitopes, Immune Epitope Database
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EpiVax
- Novozymes Biopharma
- ioGenetics
- International Society of Vaccines
- IMGT
- Dassault Systemes
- Certara
- Chemical Computing Group
- Compugen
- Genedata AG
- Insilico Biotechnology AG
- Leadscope Inc
- Nimbus Discovery
- Strand Life Sciences
- Schrodinger
- Simulation Plus
- Rosa & Co
Highlights of The Immunoinformatics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cancer Diagnosis & Therapy
- Reverse Vaccinology
- Immune System Modeling
- By Application:
- Allergy Prediction Databases
- Analysis Resource Database
- International Immunogenetics System
- The Ontology of Immune Epitopes
- Immune Epitope Database
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunoinformatics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immunoinformatics is the study of how the immune system works and how it can be used to diagnose and treat diseases.
Some of the major players in the immunoinformatics market are EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group, Compugen, Genedata AG, Insilico Biotechnology AG, Leadscope Inc, Nimbus Discovery, Strand Life Sciences, Schrodinger, Simulation Plus, Rosa & Co.
The immunoinformatics market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunoinformatics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunoinformatics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunoinformatics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunoinformatics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunoinformatics Market Size & Forecast, 2018-2028
4.5.1 Immunoinformatics Market Size and Y-o-Y Growth
4.5.2 Immunoinformatics Market Absolute $ Opportunity
Chapter 5 Global Immunoinformatics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Immunoinformatics Market Size Forecast by Type
5.2.1 Cancer Diagnosis & Therapy
5.2.2 Reverse Vaccinology
5.2.3 Immune System Modeling
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Immunoinformatics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Immunoinformatics Market Size Forecast by Applications
6.2.1 Allergy Prediction Databases
6.2.2 Analysis Resource Database
6.2.3 International Immunogenetics System
6.2.4 The Ontology of Immune Epitopes
6.2.5 Immune Epitope Database
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immunoinformatics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunoinformatics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunoinformatics Analysis and Forecast
9.1 Introduction
9.2 North America Immunoinformatics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunoinformatics Market Size Forecast by Type
9.6.1 Cancer Diagnosis & Therapy
9.6.2 Reverse Vaccinology
9.6.3 Immune System Modeling
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Immunoinformatics Market Size Forecast by Applications
9.10.1 Allergy Prediction Databases
9.10.2 Analysis Resource Database
9.10.3 International Immunogenetics System
9.10.4 The Ontology of Immune Epitopes
9.10.5 Immune Epitope Database
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Immunoinformatics Analysis and Forecast
10.1 Introduction
10.2 Europe Immunoinformatics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunoinformatics Market Size Forecast by Type
10.6.1 Cancer Diagnosis & Therapy
10.6.2 Reverse Vaccinology
10.6.3 Immune System Modeling
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Immunoinformatics Market Size Forecast by Applications
10.10.1 Allergy Prediction Databases
10.10.2 Analysis Resource Database
10.10.3 International Immunogenetics System
10.10.4 The Ontology of Immune Epitopes
10.10.5 Immune Epitope Database
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Immunoinformatics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunoinformatics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunoinformatics Market Size Forecast by Type
11.6.1 Cancer Diagnosis & Therapy
11.6.2 Reverse Vaccinology
11.6.3 Immune System Modeling
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Immunoinformatics Market Size Forecast by Applications
11.10.1 Allergy Prediction Databases
11.10.2 Analysis Resource Database
11.10.3 International Immunogenetics System
11.10.4 The Ontology of Immune Epitopes
11.10.5 Immune Epitope Database
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Immunoinformatics Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunoinformatics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunoinformatics Market Size Forecast by Type
12.6.1 Cancer Diagnosis & Therapy
12.6.2 Reverse Vaccinology
12.6.3 Immune System Modeling
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Immunoinformatics Market Size Forecast by Applications
12.10.1 Allergy Prediction Databases
12.10.2 Analysis Resource Database
12.10.3 International Immunogenetics System
12.10.4 The Ontology of Immune Epitopes
12.10.5 Immune Epitope Database
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Immunoinformatics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunoinformatics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunoinformatics Market Size Forecast by Type
13.6.1 Cancer Diagnosis & Therapy
13.6.2 Reverse Vaccinology
13.6.3 Immune System Modeling
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Immunoinformatics Market Size Forecast by Applications
13.10.1 Allergy Prediction Databases
13.10.2 Analysis Resource Database
13.10.3 International Immunogenetics System
13.10.4 The Ontology of Immune Epitopes
13.10.5 Immune Epitope Database
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immunoinformatics Market: Competitive Dashboard
14.2 Global Immunoinformatics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 EpiVax
14.3.2 Novozymes Biopharma
14.3.3 ioGenetics
14.3.4 International Society of Vaccines
14.3.5 IMGT
14.3.6 Dassault Systemes
14.3.7 Certara
14.3.8 Chemical Computing Group
14.3.9 Compugen
14.3.10 Genedata AG
14.3.11 Insilico Biotechnology AG
14.3.12 Leadscope Inc
14.3.13 Nimbus Discovery
14.3.14 Strand Life Sciences
14.3.15 Schrodinger
14.3.16 Simulation Plus
14.3.17 Rosa & Co
